CFO
CLX icon

CVA Family Office’s Clorox CLX Stock Holding History

CVA Family Office’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.8K Sell
637
-66
-9% -$6.33K 0.01% 568
2026
Q1 		$72.9K Sell
703
-128
-15% -$14.5K 0.01% 520
2025
Q4 		$83.8K Sell
831
-3
-0.4% -$326 0.01% 457
2025
Q3 		$103K Buy
834
+292
+54% +$36.2K 0.01% 413
2025
Q2 		$65.1K Buy
542
+5
+0.9% +$667 0.01% 495
2025
Q1 		$79.1K Sell
537
-17
-3% -$2.6K 0.01% 434
2024
Q4 		$90K Buy
554
+13
+2% +$2.13K 0.01% 408
2024
Q3 		$88.1K Hold
541
– – 0.01% 399
2024
Q2 		$73.8K Buy
541
+11
+2% +$1.53K 0.01% 419
2024
Q1 		$81.1K Hold
530
– – 0.01% 398
2023
Q4 		$75.6K Buy
+530
New +$70.7K 0.01% 381
2023
Q3 		– Sell
-505
Closed -$80.3K – 366
2023
Q2 		$80.3K Hold
505
– – 0.02% 348
2023
Q1 		$79.9K Buy
505
+5
+1% +$750 0.02% 343
2022
Q4 		$70.2K Sell
500
-55
-10% -$7.81K 0.02% 342
2022
Q3 		$71K Buy
555
+35
+7% +$5.05K 0.02% 294
2022
Q2 		$73K Hold
520
– – 0.02% 288
2022
Q1 		$72K Sell
520
-15
-3% -$2.3K 0.02% 320
2021
Q4 		$93K Sell
535
-110
-17% -$18.3K 0.02% 257
2021
Q3 		$136K Sell
645
-20
-3% -$3.44K 0.1% 104
2021
Q2 		$120K Buy
665
+5
+0.8% +$913 0.03% 215
2021
Q1 		$127K Buy
660
+15
+2% +$2.89K 0.05% 154
2020
Q4 		$130K Hold
645
– – 0.08% 113
2020
Q3 		$136K Buy
645
+145
+29% +$32.3K 0.1% 104
2020
Q2 		$110K Hold
500
– – 0.09% 108
2020
Q1 		$87K Buy
+500
New +$82.6K 0.09% 108

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CVA Family Office's CLX Position: Q2 2026 in Review

CVA Family Office reduced its Clorox (CLX) stake by 9.4% in Q2 2026, selling an estimated $6.33K and leaving 637 shares worth $60.8K. The position accounts for 0.01% of the portfolio, ranked #568.

CVA Family Office first reported a position in CLX in Q1 2020 and has held it in 25 quarters since. The position peaked at $136K in Q3 2021. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • CVA Family Office held 637 shares of Clorox worth $60.8K as of Q2 2026.
  • CVA Family Office sold 66 Clorox shares in Q2 2026, an estimated $6.33K.
  • Clorox made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #568 holding.
  • CVA Family Office first reported a position in Clorox in Q1 2020 and has held it in 25 quarters since.
  • CVA Family Office's Clorox position peaked at $136K in Q3 2021.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.